NKGN NKGen Biotech Inc.
NKGen Biotech (NKGN) news
NKGen Biotech Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker NKGN, recorded under United States. The directory classifies it as Cell therapy. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest NKGen Biotech news
We have not published a story on NKGen Biotech yet. When there is news, it will appear here.
Questions about NKGen Biotech
What is the ticker symbol of NKGen Biotech?
NKGen Biotech Inc. trades under the ticker NKGN on OTC.
Where is NKGen Biotech listed?
NKGen Biotech Inc. is listed on OTC.
Which country or territory is NKGen Biotech listed under?
Our directory records NKGen Biotech Inc. under United States.
What does NKGen Biotech do?
Our directory classifies NKGen Biotech Inc. as: Cell therapy. This is a directory classification, not a description of the pipeline.
What is the ISIN of NKGen Biotech?
The ISIN recorded for NKGen Biotech Inc. is US65488A1016.
Does aibio.space cover NKGen Biotech?
aibio.space lists NKGen Biotech Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Which companies are similar to NKGen Biotech?
Companies in our directory listed in the same country and business area as NKGen Biotech: CYIOS, Fennec Pharmaceuticals, Stereotaxis, Nkarta, Cresco Labs, Rani Therapeutics Holdings.
Investor discussion: NKGen Biotech
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- NKGen Biotech Inc.
- Ticker
- NKGN
- Listing
- OTC
- Country or territory
- United States
- Business scope
- Cell therapy
- ISIN
- US65488A1016
- Last quote in directory
- 2026-10-20
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio